Suppression of Lipogenesis via Reactive Oxygen Species-AMPK Signaling for Treating Malignant and Proliferative Diseases. [electronic resource]
- Antioxidants & redox signaling 02 2018
- 339-357 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-7716
10.1089/ars.2017.7090 doi
AMP-Activated Protein Kinases--genetics Arthritis, Rheumatoid--drug therapy Berberine--administration & dosage Carcinoma, Non-Small-Cell Lung--drug therapy Cell Line, Tumor Cell Proliferation--drug effects Drug Resistance, Neoplasm--genetics Fibroblasts--drug effects Gefitinib Gene Expression Regulation--drug effects Humans Lipogenesis--genetics Oxidation-Reduction Quinazolines--administration & dosage Reactive Oxygen Species--metabolism Signal Transduction--drug effects Sterol Regulatory Element Binding Protein 1--genetics Synovial Fluid--drug effects